HA

Hemangkumar Amrutlal Sukhanandi

Active Director Director DIN 07663066
DIN 07663066 First appointment Jan 2017 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemangkumar Amrutlal Sukhanandi

Data last updated:

Hemangkumar Amrutlal Sukhanandi is a Director at Ozean Pharma Private Limited (since 2017). The company operates in Electrnoics.

DIN 07663066
Primary Designation Director
Industry Electrnoics
First Appointment 09 Jan 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ozean Pharma Private Limited U52609GJ2017PTC095051
Director09 Jan 20172017Active

Board colleagues of Hemangkumar Amrutlal Sukhanandi

Directorship timeline

Open interactive timeline →
Ozean Pharma Private Limited
Premium access

Shareholding and investment profile for Hemangkumar Amrutlal Sukhanandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemangkumar Amrutlal Sukhanandi

Hemangkumar Amrutlal Sukhanandi currently holds 1 directorship: Ozean Pharma Private Limited (Director, since 09 Jan 2017).

Hemangkumar Amrutlal Sukhanandi was first appointed on 09 Jan 2017 as Director at Ozean Pharma Private Limited.

The current boards of Hemangkumar Amrutlal Sukhanandi's companies include Adarshkumar Nareshbhai Kantariya (Ozean Pharma Private Limited), Nirmal Lakhabhai Modhvadiya (Ozean Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available